Working… Menu

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03204019
Recruitment Status : Unknown
Verified June 2017 by yihebali chi, Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : June 29, 2017
Last Update Posted : June 29, 2017
Information provided by (Responsible Party):
yihebali chi, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2017
Estimated Study Completion Date : September 2018